Clinical Trial

Comparison of Anesthetic Efficacy OF 2% Lidocaine Inferior Alveolar Nerve (IANB) Block Versus Primary Buccal Infilteration With 4% Articaine in Symptomatic Irreversible Pulpitis(SIP) IN Mandibular First Molars

Study acronym: IANB SIP EPT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to compare the anesthetic efficacy of 2% lignocaine administered through an inferior alveolar nerve block (IANB) in one group of participants with 4% articaine delivered via primary buccal infiltration in other group in patients with symptomatic irreversible pulpitis in mandibular first molars.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-31
minor Completion moved earlier: 2027-02-01 -> 2026-08-20 2026-07-31
Trial Details
NCT Number NCT07409896
Lead Sponsor Armed Forces Institute of Dentistry, Pakistan
Conditions Anesthetic Efficacy
Enrollment 330 participants
Start Date 2026-03-20
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-30